Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
…, GG Sokos, G Miske, A Shah, D Elahi, RP Shannon - Circulation, 2004 - Am Heart Assoc
Background— Glucose-insulin-potassium infusions are beneficial in uncomplicated patients
with acute myocardial infarction (AMI) but are of unproven efficacy in AMI with left ventricular …
with acute myocardial infarction (AMI) but are of unproven efficacy in AMI with left ventricular …
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant …
…, M Ewer, D Keefe, RP Shannon… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Trastuzumab is effective in treating human epidermal growth factor receptor 2 (HER2)
–positive breast cancer, but it increases frequency of cardiac dysfunction (CD) when …
–positive breast cancer, but it increases frequency of cardiac dysfunction (CD) when …
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
…, LA Nikolaidis, S Mankad, D Elahi, RP Shannon - Journal of cardiac …, 2006 - Elsevier
BACKGROUND: Insulin resistance is present in the setting of congestive heart failure.
Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin with both insulinotropic and …
Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin with both insulinotropic and …
Diabetic cardiomyopathy: the search for a unifying hypothesis
IG Poornima, P Parikh, RP Shannon - Circulation research, 2006 - Am Heart Assoc
Although diabetes is recognized as a potent and prevalent risk factor for ischemic heart disease,
less is known as to whether diabetes causes an altered cardiac phenotype independent …
less is known as to whether diabetes causes an altered cardiac phenotype independent …
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival
…, J Chen, BD McCauley, SE Kimmel, RP Shannon - Circulation, 2010 - Am Heart Assoc
Background— Overly aggressive diuresis leading to intravascular volume depletion has been
proposed as a cause for worsening renal function during the treatment of decompensated …
proposed as a cause for worsening renal function during the treatment of decompensated …
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated …
…, L Zourelias, C Stolarski, Y Shen, RP Shannon - Circulation, 2004 - Am Heart Assoc
Background— The failing heart demonstrates a preference for glucose as its metabolic
substrate. Whether enhancing myocardial glucose uptake favorably influences left ventricular (LV…
substrate. Whether enhancing myocardial glucose uptake favorably influences left ventricular (LV…
Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts
…, H Bolukoglu, I Poornima, YT Shen, RP Shannon - … of Pharmacology and …, 2006 - ASPET
Recent evidence suggests that glucagon-like peptide-1 (GLP-1) enhances recovery of left
ventricular (LV) function after transient coronary artery occlusion. However, it is uncertain …
ventricular (LV) function after transient coronary artery occlusion. However, it is uncertain …
Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy
…, D Elahi, YT Shen, RP Shannon - American Journal of …, 2005 - journals.physiology.org
We have shown previously that the glucagon-like peptide-1 (GLP-1)-(7–36) amide increases
myocardial glucose uptake and improves left ventricular (LV) and systemic hemodynamics …
myocardial glucose uptake and improves left ventricular (LV) and systemic hemodynamics …
Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting
…, G Marrone, DH Benckart, D Elahi, RP Shannon - The American journal of …, 2007 - Elsevier
Increasing evidence suggests that tight glycemic control improves clinical outcomes after
coronary artery bypass grafting (CABG). However, the risk for hypoglycemia with insulin often …
coronary artery bypass grafting (CABG). However, the risk for hypoglycemia with insulin often …
Patient-centered community health worker intervention to improve posthospital outcomes: a randomized clinical trial
…, S McCollum, J Sellman, RP Shannon… - JAMA internal …, 2014 - jamanetwork.com
Importance Socioeconomic and behavioral factors can negatively influence posthospital
outcomes among patients of low socioeconomic status (SES). Traditional hospital personnel …
outcomes among patients of low socioeconomic status (SES). Traditional hospital personnel …